# Antitumor activity and safety of the PARP inhibitor rucaparib in patients with high-grade ovarian carcinoma and a germline or somatic BRCA1 or BRCA2 mutation: Integrated analysis of data from Study 10 and ARIEL2

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/antitumor-activity-and-safety-of-the-parp-inhibitor-rucaparib-in-patients-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Amit M. Oza,Anna V. Tinker,Ana Oaknin,Ronnie Shapira‐Frommer,Iain A. McNeish,Elizabeth M. Swisher,Isabelle Ray‐Coquard,Katherine M. Bell‐McGuinn,Robert L. Coleman,David M. O’Malley,Alexandra Léary,Lee-may Chen,Diane Provencher,Ling Ma,James D. Brenton,Gottfried E. Konecny,Cesar M. Castro,Heidi Giordano,Lara Maloney,Sandra Goble,Kevin K. Lin,James Sun,Mitch Raponi,Lindsey Rolfe,Rebecca Kristeleit |
| Citations | 278 |
| DOI | 10.1016/j.ygyno.2017.08.022 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.gynecologiconcology-online.net/article/S009082581731260X/pdf |
| OpenAlex ID | https://openalex.org/W2751912349 |
| PMID | 28882436 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Amit M. Oza](https://scholariq.org/researchers/amit-m-oza/)
- [David M. O’Malley](https://scholariq.org/researchers/david-m-o-malley/)
- [Elizabeth M. Swisher](https://scholariq.org/researchers/elizabeth-m-swisher/)
- [Robert L. Coleman](https://scholariq.org/researchers/robert-l-coleman/)
- [Rebecca Kristeleit](https://scholariq.org/researchers/rebecca-kristeleit/)

## Paper journal

- [Gynecologic Oncology](https://scholariq.org/journals/gynecologic-oncology/)

## Paper primary topic

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

## Paper topics

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.